Aris Angelis

2.1k total citations
40 papers, 1.3k citations indexed

About

Aris Angelis is a scholar working on Economics and Econometrics, General Health Professions and Ophthalmology. According to data from OpenAlex, Aris Angelis has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Economics and Econometrics, 9 papers in General Health Professions and 6 papers in Ophthalmology. Recurrent topics in Aris Angelis's work include Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (16 papers) and Healthcare cost, quality, practices (6 papers). Aris Angelis is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (16 papers) and Healthcare cost, quality, practices (6 papers). Aris Angelis collaborates with scholars based in United Kingdom, Spain and United States. Aris Angelis's co-authors include Panos Kanavos, David Tordrup, Ansgar Lange, Elena Nicod, Timothy L. Jackson, Federico Grimaccia, Andrew Simpson, Gilberto Montibeller, Lawrence D. Phillips and A Toby Prevost and has published in prestigious journals such as The Lancet Oncology, Social Science & Medicine and BMJ.

In The Last Decade

Aris Angelis

38 papers receiving 1.3k citations

Peers

Aris Angelis
Elena Nicod United Kingdom
David F. Friedlander United States
Festus Njuguna Kenya
José Miguel Cruz United States
Maysa Al‐Hussaini Jordan
Kerstin Noëlle Vokinger Switzerland
Kristin Anderson United States
Jessamy Watkins United Kingdom
Gary C. Doolittle United States
Hussein Z Noorani Canada
Elena Nicod United Kingdom
Aris Angelis
Citations per year, relative to Aris Angelis Aris Angelis (= 1×) peers Elena Nicod

Countries citing papers authored by Aris Angelis

Since Specialization
Citations

This map shows the geographic impact of Aris Angelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aris Angelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aris Angelis more than expected).

Fields of papers citing papers by Aris Angelis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aris Angelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aris Angelis. The network helps show where Aris Angelis may publish in the future.

Co-authorship network of co-authors of Aris Angelis

This figure shows the co-authorship network connecting the top 25 collaborators of Aris Angelis. A scholar is included among the top collaborators of Aris Angelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aris Angelis. Aris Angelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelis, Aris, Martin Harker, John Cairns, et al.. (2023). The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual. Value in Health. 26(10). 1503–1509. 8 indexed citations
2.
Angelis, Aris, Ajay Aggarwal, Alec Miners, et al.. (2023). The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?. Journal of the Royal Society of Medicine. 116(10). 324–330. 1 indexed citations
3.
Angelis, Aris, Jemima E. Mellerio, & Panos Kanavos. (2022). Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study. Orphanet Journal of Rare Diseases. 17(1). 346–346. 6 indexed citations
4.
Angelis, Aris, Huseyin Naci, & Allan Hackshaw. (2020). Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies. PharmacoEconomics. 38(12). 1297–1308. 27 indexed citations
5.
Angelis, Aris, Mark Linch, Gilberto Montibeller, et al.. (2019). Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework. Social Science & Medicine. 246. 112595–112595. 28 indexed citations
6.
Angelis, Aris & Panos Kanavos. (2017). Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework. Social Science & Medicine. 188. 137–156. 143 indexed citations
7.
Angelis, Aris, Ansgar Lange, & Panos Kanavos. (2017). Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. The European Journal of Health Economics. 19(1). 123–152. 203 indexed citations
8.
Angelis, Aris, Gilberto Montibeller, Daniel Hochhauser, & Panos Kanavos. (2017). Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting. BMC Medical Informatics and Decision Making. 17(1). 149–149. 25 indexed citations
9.
10.
Angelis, Aris, Panos Kanavos, Julio López‐Bastida, Renata Linertová, & Pedro Serrano‐Aguilar. (2016). Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom. BMC Musculoskeletal Disorders. 17(1). 321–321. 21 indexed citations
11.
12.
Nicod, Elena, Timothy L. Jackson, Federico Grimaccia, et al.. (2015). Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. The European Journal of Health Economics. 17(8). 991–999. 5 indexed citations
13.
Angelis, Aris, Panos Kanavos, Julio López‐Bastida, et al.. (2015). Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom. BMC Health Services Research. 15(1). 428–428. 47 indexed citations
14.
Angelis, Aris & Panos Kanavos. (2014). Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement: an Empirical Case Study. Value in Health. 17(7). A552–A552. 3 indexed citations
15.
Angelis, Aris, David Tordrup, & Panos Kanavos. (2014). Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health Policy. 119(7). 964–979. 202 indexed citations
16.
Kanavos, Panos & Aris Angelis. (2014). Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?. Pharmaceutical Medicine. 28(5). 245–248. 2 indexed citations
17.
Nicod, Elena, Timothy L. Jackson, Federico Grimaccia, Aris Angelis, & Panos Kanavos. (2013). Cost Analysis Of Pars Plana Vitrectomy For The Treatment Of Symptomatic Vitreomacular Adhesion: A Bottom-Up Costing Perspective. Value in Health. 16(3). A176–A176. 5 indexed citations
18.
Jackson, Timothy L., Elena Nicod, Aris Angelis, et al.. (2013). PARS PLANA VITRECTOMY FOR VITREOMACULAR TRACTION SYNDROME. Retina. 33(10). 2012–2017. 79 indexed citations
19.
Angelis, Aris & Panos Kanavos. (2013). A Multiple Criteria Decision Analysis Framework For Value Based Assessment Of New Medical Technologies. Value in Health. 16(3). A53–A53. 3 indexed citations
20.
Tordrup, David, Aris Angelis, & Panos Kanavos. (2013). Preferences on Policy Options for Ensuring the Financial Sustainability of Health Care Services in the Future: Results of a Stakeholder Survey. Applied Health Economics and Health Policy. 11(6). 639–652. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Nicod Breakdown of academic impact, for papers by David F. Friedlander Breakdown of academic impact, for papers by Festus Njuguna Breakdown of academic impact, for papers by José Miguel Cruz Breakdown of academic impact, for papers by Maysa Al‐Hussaini Breakdown of academic impact, for papers by Kerstin Noëlle Vokinger Breakdown of academic impact, for papers by Kristin Anderson Breakdown of academic impact, for papers by Jessamy Watkins Breakdown of academic impact, for papers by Gary C. Doolittle Breakdown of academic impact, for papers by Hussein Z Noorani
Rankless by CCL
2026